Correlation Between Aerovate Therapeutics and WPLAU

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and WPLAU at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and WPLAU into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and WPLAU 37 15 MAR 28, you can compare the effects of market volatilities on Aerovate Therapeutics and WPLAU and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of WPLAU. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and WPLAU.

Diversification Opportunities for Aerovate Therapeutics and WPLAU

0.8

Correlation Coefficient

Aerovate Therapeutics  WPLAU

Very poor diversification

The 3 months correlation between Aerovate and WPLAU is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and WPLAU 37 15 MAR 28 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WPLAU 37 15 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with WPLAU. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WPLAU 37 15 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and WPLAU go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and WPLAU

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the WPLAU. In addition to that, Aerovate Therapeutics is 11.43 times more volatile than WPLAU 37 15 MAR 28. It trades about 0.0 of its total potential returns per unit of risk. WPLAU 37 15 MAR 28 is currently generating about -0.01 per unit of volatility. If you would invest  9,413  in WPLAU 37 15 MAR 28 on September 21, 2024 and sell it today you would lose (42.00) from holding WPLAU 37 15 MAR 28 or give up 0.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	13.33%
Values	Daily Returns

Aerovate Therapeutics  vs.  WPLAU 37 15 MAR 28

Aerovate Therapeutics

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

WPLAU 37 15

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days WPLAU 37 15 MAR 28 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for WPLAU 37 15 MAR 28 investors.

Pair Trading with Aerovate Therapeutics and WPLAU

The main advantage of trading using opposite Aerovate Therapeutics and WPLAU positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, WPLAU can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WPLAU will offset losses from the drop in WPLAU's long position.

The idea behind Aerovate Therapeutics and WPLAU 37 15 MAR 28 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.